Current concepts in the management of stroke in children with sickle cell disease

Child's Nervous System

Volumn 27, Issue 7, 2011, Pages 1037-1043

  Islam, M S ^a   Anoop, P ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Cell; Disease; Prevention; Sickle; Stroke

Indexed keywords

HYDROXYUREA;

BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; DISEASE PREDISPOSITION; DOPPLER ECHOGRAPHY; EVIDENCE BASED MEDICINE; HIGH RISK POPULATION; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA; STROKE; TREATMENT PLANNING;

ANEMIA, SICKLE CELL; CHILD; HUMANS; STROKE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 79959599391     PISSN: 02567040     EISSN: 14330350     Source Type: Journal    
DOI: 10.1007/s00381-011-1394-0     Document Type: Review

References (40)

1. Herrick JB (1910) Peculiar elongated and sickle-shaped red corpuscles in a case of severe anemia. Arch Intern Med 6:517-521
2. Ingram VM (1957) Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin. Nature 180(4581):326-328
3. Verduzco LA, Nathan DG (2009) Sickle cell disease and stroke. Blood 114(25):5117-5125
4. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW et al (1998) Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 91(1):288-294 (Pubitemid 28018756)
5. Broderick J, Talbot GT, Prenger E, Leach A, Brott T (1993) Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J Child Neurol 8(3):250-255 (Pubitemid 23215715)
6. Adams RJ, McKie VC, Carl EM, Nichols FT, Perry R, Brock K et al (1997) Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol 42(5):699-704 (Pubitemid 27481541)
7. Switzer JA, Hess DC, Nichols FT, Adams RJ (2006) Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol 5(6):501-512
8. Pegelow CH, Macklin EA, Moser FG, Wang WC, Bello JA, Miller ST (2002) Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood 99(8):3014-3018 (Pubitemid 34525393)
9. Merkel KH, Ginsberg PL, Parker JC Jr, Post MJ (1978) Cerebrovascular disease in sickle cell anemia: a clinical, pathological and radiological correlation. Stroke 9(1):45-52 (Pubitemid 8287778)
10. Hsu LL, Miller ST, Wright E, Kutlar A, McKie V, Wang W et al (2003) Alpha Thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia. J Pediatr Hematol Oncol 25(8):622-628 (Pubitemid 36959423)
11. Kirkham FJ (2007) Therapy insight: stroke risk and its management in patients with sickle cell disease. Nat Clin Pract Neurol 3 (5):264-278
12. Strouse JJ, Hulbert ML, DeBaun MR, Jordan LC, Casella JF (2006) Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids. Pediatrics 118(5):1916-1924 (Pubitemid 46393673)
13. Pappachan J, Kirkham FJ (2008) Cerebrovascular disease and stroke. Arch Dis Child 93(10):890-898
14. Wang W, Enos L, Gallagher D, Thompson R, Guarini L, Vichinsky E et al (2001) Neuropsychologic performance in school-aged children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr 139(3):391-397 (Pubitemid 32889516)
15. Schatz J, White DA, Moinuddin A, Armstrong M, DeBaun MR (2002) Lesion burden and cognitive morbidity in children with sickle cell disease. J Child Neurol 17(12):891-895 (Pubitemid 36231052)
16. Miller ST, Macklin EA, Pegelow CH, Kinney TR, Sleeper LA, Bello JA et al (2001) Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr 139 (3):385-390 (Pubitemid 32889515)
17. Wilimas J, Goff JR, Anderson HR Jr, Langston JW, Thompson E (1980) Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents. J Pediatr 96(2):205-208 (Pubitemid 10129397)
18. Russell MO, Goldberg HI, Hodson A, Kim HC, Halus J, Reivich M, Schwartz E (1984) Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood 63(1):162-169 (Pubitemid 14224534)
19. Wang WC, Kovnar EH, Tonkin IL, Mulhern RK, Langston JW, Day SW et al (1991) High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. J Pediatr 118(3):377-382
20. Cohen AR, Martin MB, Silber JH, Kim HC, Ohene-Frempong K, Schwartz E (1992) A modified transfusion program for prevention of stroke in sickle cell disease. Blood 79(7):1657-1661
21. Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C et al (1998) Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 339(1):5-11 (Pubitemid 28304491)
22. Adams RJ, Brambilla D, Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators (2005) Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 353(26):2769-2778
23. Casella JF, King AA, Barton B, White DA, Noetzel MJ, Ichord RN (2010) Design of the silent cerebral infarct transfusion (SIT) trial. Pediatr Hematol Oncol 27(2):69-89
24. Ware RE, Zimmerman SA, Schultz WH (1999) Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease. Blood 94(9):3022-3026 (Pubitemid 29512706)
25. Sumoza A, de Bisotti R, Sumoza D, Fairbanks V (2002) Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA). Am J Hematol 71(3):161-165 (Pubitemid 35253329)
26. Gulbis B, Haberman D, Dufour D, Christophe C, Vermylen C, Kagambega F et al (2005) Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience. Blood 105(7):2685-2690 (Pubitemid 40446257)
27. Ware RE, Zimmerman SA, Sylvestre PB, Mortier NA, Davis JS, Treem WR et al (2004) Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy. J Pediatr 145 (3):346-352 (Pubitemid 39165683)
28. Clinical trails portfolio. Stroke with transfusions changing to hydroxyurea (SWITCH). http://clinicaltrials.gov/ct2/show/NCT00122980, accessed 29 September 2010
29. Walters MC, Patience M, Leisenring W, Eckman JR, Scott JP, Mentzer WC et al (1996) Bone marrow transplantation for sickle cell disease. N Engl J Med 335(6):369-376 (Pubitemid 26257244)
30. Nietert PJ, Abboud MR, Silverstein MD, Jackson SM (2000) Bone marrow transplantation versus periodic prophylactic blood transfusion in sickle cell patients at high risk of ischemic stroke: a decision analysis. Blood 95(10):3057-3064 (Pubitemid 30321154)
31. Walters MC, Storb R, Patience M, Leisenring W, Taylor T, Sanders JE et al (2000) Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood 95(6):1918-1924 (Pubitemid 30151626)
32. Steen RG, Helton KJ, Horwitz EM, Benaim E, Thompson S, Bowman LC et al (2001) Improved cerebrovascular patency following therapy in patients with sickle cell disease: initial results in 4 patients who received HLA-identical hematopoietic stem cell allografts. Ann Neurol 49(2):222-229 (Pubitemid 32157998)
33. Adams RJ (2007) Big strokes in small persons. Arch Neurol 64 (11):1567-1574
34. Adams RJ, McKie VC, Brambilla D, Carl E, Gallagher D, Nichols FT et al (1998) Stroke prevention trial in sickle cell anemia. Control Clin Trials 19(1):110-129 (Pubitemid 28085558)
35. Clinical Effectiveness and Evaluation Unit, Royal College of Physicians, London. Stroke in childhood: clinical guidelines for diagnosis, management and rehabilitation. http://www.rcplondon.ac.uk/pubs/books/childstroke/childstroke- guidelines.pdf, accessed 29 September 2010
36. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV et al (1995) Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 332 (20):1317-1322
37. Charache S, Barton FB, Moore RD, Terrin ML, Steinberg MH, Dover GJ et al (1996) Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent: The Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Medicine (Baltimore) 75(6):300-326
38. Adragna NC, Fonseca P, Lauf PK (1994) Hydroxyurea affects cell morphology, cation transport and red blood cell adhesion on cultured vascular endothelial cells. Blood 83(2):553-560 (Pubitemid 24030584)
39. McQuaker IG, Jaspan T, McConachie NS, Dolan G (1999) Coil embolization of cerebral aneurysms in patients with sickling disorders. Br J Haematol 106(2):388-390 (Pubitemid 29450662)
40. Woodard P, Helton KJ, Khan RB, Hale GA, Phipps S, Wang Wet al (2005) Brain parenchymal damage after haematopoietic stem cell transplantation for severe sickle cell disease. Br J Haematol 129(4):550-552